Answers are grounded in this paper and cite their sources.
Background: Vascular endothelial growth factor (VEGF) is a crucial regulator of physiological and pathological angiogenesis.Increased VEGF expression has been linked with inappropriate VEGF-induced angiogenesis in various disease pathologies including cancers.Methodology: In this case-control study, DNA samples of 319 esophageal squamous cell cancer (ESCC) patients and 354 healthy controls from Punjab, North-West India, were screened for VEGF-417T/C, -172C/A, -165C/T, -160C/T, -152G/A, -141A/C, and -116G/A promoter polymorphisms using Sanger sequencing.Results: AA genotype and A allele of both VEGF-152G/A and -116G/A polymorphisms were significantly associated with elevated risk to ESCC in total subjects as well as in female group.CT genotype and T allele of VEGF-165C/T polymorphism were significantly associated with reduced risk for ESCC only in female group.Body mass index-based stratification analysis revealed significant association of AA genotype and A allele of VEGF-152G/A and A allele of VEGF-116G/A polymorphism with an increased risk to ESCC in nonobese patients.Linkage disequilibrium was observed between VEGF-165C/T and VEGF-141A/C (D 0 = 0.88, r 2 = 0.68) and between VEGF-152G/A and VEGF-116G/A (D 0 = 0.93, r 2 = 0.49) polymorphisms.Haplotype T-C-C-C-A-A-A was significantly associated with increased ESCC risk in total subjects as well as in female group.Conclusion: From this study, we concluded that VEGF-116 G/A and VEGF-152G/A polymorphisms were significantly associated with increased ESCC risk in total patients as well as in female group, whereas VEGF-165 C/T polymorphism was associated with reduced risk only in female group.
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: